Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
British Journal of Haematology|June 6, 2003
Viral antigen-specific CD8+ T-cell responses are impaired in multiple myelomaBritta Maecker, Karen S Anderson, Michael S von Bergwelt-Baildon, et al.American Journal of Hematology|July 24, 2010
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström MacroglobulinemiaIrene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker ConsortiumDaphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical propertiesSamantha Pozzi, Sonia Vallet, Siddhartha Mukherjee, et al.Journal of Pain and Symptom Management|May 28, 2026
Social Determinants of Health And End-Of-Life Circumstances in A Quaternary Children's HospitalTara Jamieson, Jessica P Liu, Sarah W Goldberg, et al.Leukemia & Lymphoma|May 3, 2008
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemiaXavier Leleu, Anne-Sophie Moreau, Edie Weller, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2002
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantationEdwin P Alyea, Edie Weller, David C Fisher, et al.Cancer Research|September 5, 2002
The vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584 inhibits growth and migration of multiple myeloma cells in the bone marrow microenvironmentBoris Lin, Klaus Podar, Deepak Gupta, et al.Blood|October 30, 2010
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myelomaJacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, et al.British Journal of Haematology|June 3, 2015
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinationsCindy Varga, Wanling Xie, Jacob Laubach, et al.Pageof 8